EARLY HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION IN PATIENTS WITH HIGH-RISK, AGGRESSIVE NON-HODGKINS-LYMPHOMA

被引：0
|
作者：
BRUGGER, W
GRAMATZKI, M
KOLLMANNSBERGER, C
KIEFER, T
MERTELSMANN, R
KANZ, L
机构：
[1] UNIV FREIBURG,MED CTR,DEPT HEMATOL ONCOL,W-7800 FREIBURG,GERMANY
[2] UNIV ERLANGEN NURNBERG,MED CTR,W-8520 ERLANGEN,GERMANY
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A234 / A234
页数：1
相关论文
共 50 条
  • [1] Autologous peripheral-blood progenitor-cell support following high-dose chemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma
    Marit, G
    Faberes, C
    Pico, JL
    Boiron, JM
    Bourhis, JH
    Brault, P
    Bernard, P
    Foures, C
    ConyMakhoul, P
    Puntous, M
    Vezon, G
    Broustet, A
    Girault, D
    Reiffers, J
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1306 - 1313
  • [2] SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN LOW-GRADE NON-HODGKINS-LYMPHOMA
    HAAS, R
    MOOS, M
    KARCHER, A
    MOHLE, R
    WITT, B
    GOLDSCHMIDT, H
    FRUHAUF, S
    FLENTJE, M
    WANNENMACHER, M
    HUNSTEIN, W
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (08) : 1685 - 1692
  • [3] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA
    VOSE, JM
    ANDERSON, JR
    KESSINGER, A
    BIERMAN, PJ
    COCCIA, P
    REED, EC
    GORDON, B
    ARMITAGE, JO
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 1846 - 1851
  • [4] HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT IN THE OUTPATIENT SETTING
    MICHELSON, GC
    GRINBLATT, D
    BYRNEMALLOY, R
    ZIMMERMAN, T
    WILLIAMS, SF
    CLINICAL RESEARCH, 1994, 42 (03): : A378 - A378
  • [5] TIME-COURSE OF THE RECOVERY OF CELLULAR IMMUNE FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR HIGH-GRADE NON-HODGKINS-LYMPHOMA
    SCHEID, C
    PETTENGELL, R
    GHIELMINI, M
    RADFORD, JA
    MORGENSTERN, GR
    STERN, PL
    CROWTHER, D
    BONE MARROW TRANSPLANTATION, 1995, 15 (06) : 901 - 906
  • [6] THE USE OF HEMATOPOIETIC GROWTH-FACTORS FOR HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION
    KANZ, L
    BRUGGER, W
    MERTELSMANN, R
    SEMINARS IN ONCOLOGY, 1994, 21 (06) : 10 - 18
  • [7] HIGH-DOSE CHEMOTHERAPY (HDC) WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN THE OUTPATIENT (OPC) CLINIC
    MEISENBERG, B
    MCMILLAN, R
    MILLER, W
    PIRO, L
    BLOOD, 1994, 84 (10) : A203 - A203
  • [8] BONE-MARROW RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - EFFECT OF GRAFT SIZE
    VANDERWALL, E
    RICHEL, DJ
    HOLTKAMP, MJ
    SLAPERCORTENBACH, ICM
    VANDERSCHOOT, CE
    DALESIO, O
    NOOIJEN, WJ
    SCHORNAGEL, JH
    RODENHUIS, S
    ANNALS OF ONCOLOGY, 1994, 5 (09) : 795 - 802
  • [9] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma
    Murakami, H
    Fujii, H
    Inaba, T
    Shimazaki, C
    Okamoto, S
    Miwa, A
    Sawamura, M
    Abe, M
    Chou, T
    Asaoku, H
    Kitahara, Y
    Hayashi, K
    Kosaka, M
    Togawa, A
    Takatsuki, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (03) : 169 - 173
  • [10] HIGH-DOSE THERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA
    KESSINGER, A
    ARMITAGE, JO
    SMITH, DM
    LANDMARK, JD
    BIERMAN, PJ
    WEISENBURGER, DD
    BLOOD, 1989, 74 (04) : 1260 - 1265
12345